These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 30916804)

  • 1. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
    Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
    Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
    Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
    Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insecticide use and risk of non-Hodgkin lymphoma subtypes: A subset meta-analysis of the North American Pooled Project.
    Kachuri L; Beane Freeman LE; Spinelli JJ; Blair A; Pahwa M; Koutros S; Hoar Zahm S; Cantor KP; Weisenburger DD; Pahwa P; Dosman JA; McLaughlin JR; Demers PA; Harris SA
    Int J Cancer; 2020 Dec; 147(12):3370-3383. PubMed ID: 32574374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
    Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
    Ann Hematol; 2019 May; 98(5):1169-1176. PubMed ID: 30617643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
    Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
    Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
    Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
    Br J Haematol; 2021 Nov; 195(4):552-560. PubMed ID: 34331461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
    Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
    Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.